|
|||||
|
|
A multiplicity of targets: evaluating composite endpoint studies of the GLP-1 receptor agonists in type 2 diabetes |
|
| Authors: | Stuart A. Ross |
| Affiliation: | University of Calgary, Calgary, Alberta, Canada |
| Abstract: | |
| Keywords: | Composite endpoints Exenatide GLP-1 Liraglutide Type 2 diabetes |